Cell specific role of proteolytic shedding by the metalloproteinases ADAM10 and ADAM17 in chronic lung infammation
Cell specific role of proteolytic shedding by the metalloproteinases ADAM10 and ADAM17 in chronic lung infammation
批准号:
193367644
负责人:
Professor Dr. Andreas Ludwig
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2011
资助国家:
德国
项目状态:
已结题
起止时间:
2010-12-31 至 2018-12-31
中文摘要
急性和慢性炎症是由表面表达的效应分子的活性和促炎介质的释放驱动的。金属蛋白酶ADAM10和ADAM17介导多种表面分子(细胞因子、受体、趋化因子、生长因子和黏附分子)的裂解和释放,调节血管通透性和白细胞的募集。利用细胞特异性基因敲除小鼠,我们证明了ADAM10和ADAM17在内毒素或酸性鼻腔给药引起的急性肺炎症中起着重要作用。内皮细胞的ADAM17活性与黏附分子的裂解和通透性调节有关,而平滑肌ADAM17的功能与生长因子的脱落和随后细胞的反式激活有关。在白细胞中,ADAM10而不是ADAM17通过促进白细胞的迁移、黏附和信号传递而参与急性肺炎症。除了它们在急性肺炎症中的促炎作用外,ADAM10和ADAM17在慢性炎症的后期阶段如肺纤维化和过敏性哮喘中的作用尚不清楚。在此,我们旨在研究ADAM10和ADAM17在慢性肺部炎症过程中的可能作用,以及它们作为决定进展和解决/修复之间的开关分子的功能。我们的第一个实验表明,内皮ADAM10在早期急性炎症中起到促炎作用,但在炎症的后期阶段具有保护作用。因此,我们的假设是,这两种蛋白酶通过以细胞特异性的方式脱落表面分子来不同地调节炎症的早期和晚期。因此,我们将研究ADAMS在气管内滴注博莱霉素诱导的小鼠肺部炎症和纤维化发展的不同阶段中的调节和活性,并探讨细胞特异性敲除ADAM10和ADAM17在T细胞募集、细胞因子释放、胶原产生和组织重塑中的作用。这些酶的活性将与黏附分子、生长因子、Notch和其他物质的脱落有关。对细胞迁移、通透性、介质分泌、增殖、存活、再生和反式激活的机制分析将在细胞特异性基因敲除小鼠的原代人和小鼠肺细胞和白细胞中进行,或者在药物或转录抑制ADAM10或ADAM17之后进行。同样的程序将被用来研究ADAM10和ADAM17是否也控制哮喘肺部炎症的早期和晚期,以回应OVA免疫和通过一般或疾病特异性途径的攻击。本研究将探讨ADAM蛋白水解酶在急性到慢性肺部炎症过程中的时间依赖性和细胞依赖性的功能转换。这对开发ADAM抑制剂的抗炎治疗策略具有重要意义。
英文摘要
Acute and chronic inflammation is driven by the activity of surface expressed effector molecules and the release of pro-inflammatory mediators. The metalloproteinases ADAM10 and ADAM17 mediate the cleavage and release of several surface molecules (cytokines, receptors, chemokines, growth factors and adhesion molecules) regulating vascular permeability and recruitment of leukocytes. Using cell-specific knockout mice we have demonstrated a crucial contribution of ADAM10 and ADAM17 towards acute lung inflammation induced by intranasal application of LPS or acid. While endothelial ADAM17 activity was related to the cleavage of adhesion molecules and permeability regulation, smooth muscle ADAM17 function was linked to the shedding of growth factors and subsequent transactivation of the cells. In leukocytes ADAM10 but not ADAM17 contributes to acute lung inflammation by promoting leukocyte migration, adhesion and signalling.Besides their proinflammatory function in actute lung inflammation, the contribution of ADAM10 and ADAM17 towards later stages of chronic inflammation such as lung fibrosis and allergic asthma remains completely unclear. Here we aim to investigate the possible role of ADAM10 and ADAM17 during the course of chronic lung inflammation and their function as switch molecules deciding between progression and resolution/repair. Our first experiments indicate that endothelial ADAM10 acts proinflammatory in early acute inflammation but holds a protective role at later stages of inflammation. Our hypothesis therefore is that both proteases differentially regulate early and late phases of inflammation by shedding of surface molecules in a cell-specific manner. We will therefore study the regulation and activity of ADAMs in different phases of lung inflammation and fibrosis development induced in mice by intratracheal instillation of bleomycin and investigate the role of cell-specific knockout of ADAM10 and ADAM17 for T cell recruitment, cytokine release, collagen production and tissue remodelling. The activity of the proteases will be linked to the shedding of adhesion molecules, growth factors, Notch and others. Mechanistic analysis on cell migration, permeability, mediator secretion, proliferation, survival, regeneration, and transactivation will be performed with primary human and murine lung cells and leukocytes either from cell-specific knockout mice or after pharmacological or transcriptional suppression of ADAM10 or ADAM17. The same procedure will be used to investigate whether ADAM10 and ADAM17 also control early and late phases of asthmatic lung inflammation in response to OVA immunization and challenge by general or disease specific pathways. This study shall investigate the time- and cell-dependent functional switch of ADAM proteases in the course from actute to chronic lung inflammation. This should have important implications for the development of antinfammatory treatment strategies with ADAM inhibitors.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Micro fluidic system for characterization of endothelial permeability and transendothelial leucocyte migration
-
批准号:244490310
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Professor Dr. Andreas Ludwig
-
依托单位:
Shedding proinflammatorischer Mediatoren durch die Metalloproteinasen ADAM10 und ADAM17 bei der entzündlichen Leukozytenrekrutierung
-
批准号:57402829
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Professor Dr. Andreas Ludwig
-
依托单位:
Rolle von HCN1- und HCN2-Kanälen in nozizeptiven Neuronen
-
批准号:78395041
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Professor Dr. Andreas Ludwig
-
依托单位:
Die Bedeutung von löslichen und transmembranen Varianten der Chemokine CX3CL1 und CXCL16 bei vaskulären Entzündungsreaktionen
-
批准号:34509686
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Professor Dr. Andreas Ludwig
-
依托单位:
Die Bedeutung von löslichen und transmembranen Varianten der CX3CL1 und CXCL16 bei vaskulären Entzündungsreaktionen
-
批准号:5393130
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2002
-
负责人:Professor Dr. Andreas Ludwig
-
依托单位:
Measurement of solid-liquid interface energy in ternary alloy systems
-
批准号:5341520
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2001
-
负责人:Professor Dr. Andreas Ludwig
-
依托单位:
Genetische Inaktivierung des Hyperpolarisations-aktivierten Kationenkanals HCN4
-
批准号:5238264
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2000
-
负责人:Professor Dr. Andreas Ludwig
-
依托单位:
Regulation and Function of the Rhomboid Pseudoproteases iRhom1 and iRhom2 in Lung Inflammation
-
批准号:418426903
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Andreas Ludwig
-
依托单位:
国内基金
海外基金
登录
查看更多内容
新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
-
批准号:82371711
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:吕志宝
-
依托单位:
人巨细胞病毒编码蛋白UL23调控 HCMV-specific T 细胞增殖、活性及分化的机理
-
批准号:32070149
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:李弘剑
-
依托单位:
花胶鱼类物种Species-specific PCR和Multiplex PCR鉴定体系研究
-
批准号:31902373
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2019
-
负责人:曾玲
-
依托单位:
Dravet综合征基因突变分析及突变来源研究
-
批准号:81171221
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:张月华
-
依托单位:
睾丸特异性新基因TSC29的表达调控机制及其功能研究
-
批准号:81170613
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2011
-
负责人:唐爱发
-
依托单位:
RNA结合蛋白CUG-BP1对于mRNA降解的调控机制研究
-
批准号:31000570
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:张礼斌
-
依托单位:
新生隐球菌减数分裂特异性基因ISC10的生理功能研究
-
批准号:30970130
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2009
-
负责人:潘炜华
-
依托单位:
寻找精神分裂症的调节性遗传变异
-
批准号:30870899
-
项目类别:面上项目
-
资助金额:45.0万元
-
批准年份:2008
-
负责人:David Saffen
-
依托单位: